
|Articles|June 26, 2008
HIV drug Aptivus gains new indication approval for kids
Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.
Advertisement
Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How Pharmacists Take Control of Medical Billing
2
Pharmacists Essential for Managing Patient Safety in Self-Medication
3
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
4
COVID-19 Booster Comparison Shows Higher Antibody Levels With mRNA Vaccine
5






























